Active surveillance can provide eligible patients with low-risk prostate cancer the opportunity to defer or avoid treatment and instead opt for routine monitoring of their disease; however, challenges arise when determining which patients should be eligible for this approach and how to maintain patient and provider protocol compliance.
Dr. Ronney Abaza, A World Leader in Robotic Urologic and Cancer Surgery, Joins Central Ohio Urology Group
04/06/2021 | 07:39am EDT
Send by mail :
Message :
Required fields
Central Ohio Urology Group is pleased to announce that Ronney Abaza, MD, FACS, one of the most experienced robotic surgeons in the world, has joined the group to continue his focus on robotic surgery for prostate, kidney and bladder cancers and other urological conditions. Dr. Abaza ranks in the top five internationally for robotic surgery volume with more than 6,000 procedures performed, as well as being the first in the world to perform several robotic procedures.